Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1952 2
1953 1
1954 2
1960 1
1962 1
1964 1
1966 1
1967 1
1968 1
1969 1
1970 5
1971 5
1972 10
1973 3
1974 4
1975 3
1976 4
1977 6
1978 6
1979 6
1980 6
1981 8
1982 9
1983 12
1984 15
1985 20
1986 27
1987 27
1988 31
1989 18
1990 30
1991 25
1992 21
1993 20
1994 19
1995 24
1996 17
1997 19
1998 16
1999 13
2000 24
2001 24
2002 19
2003 26
2004 22
2005 29
2006 34
2007 42
2008 37
2009 44
2010 35
2011 40
2012 52
2013 69
2014 73
2015 76
2016 66
2017 77
2018 71
2019 42
2020 22
Text availability
Article attribute
Article type
Publication date

Search Results

1,281 results
Results by year
Filters applied: . Clear all
Page 1
Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat.
Germain DP, Hughes DA, Nicholls K, Bichet DG, Giugliani R, Wilcox WR, Feliciani C, Shankar SP, Ezgu F, Amartino H, Bratkovic D, Feldt-Rasmussen U, Nedd K, Sharaf El Din U, Lourenco CM, Banikazemi M, Charrow J, Dasouki M, Finegold D, Giraldo P, Goker-Alpan O, Longo N, Scott CR, Torra R, Tuffaha A, Jovanovic A, Waldek S, Packman S, Ludington E, Viereck C, Kirk J, Yu J, Benjamin ER, Johnson F, Lockhart DJ, Skuban N, Castelli J, Barth J, Barlow C, Schiffmann R. Germain DP, et al. Among authors: Barth J. N Engl J Med. 2016 Aug 11;375(6):545-55. doi: 10.1056/NEJMoa1510198. N Engl J Med. 2016. PMID: 27509102 Free article. Clinical Trial.
Synaptotagmin-3 drives AMPA receptor endocytosis, depression of synapse strength, and forgetting.
Awasthi A, Ramachandran B, Ahmed S, Benito E, Shinoda Y, Nitzan N, Heukamp A, Rannio S, Martens H, Barth J, Burk K, Wang YT, Fischer A, Dean C. Awasthi A, et al. Among authors: Barth J. Science. 2019 Jan 4;363(6422):eaav1483. doi: 10.1126/science.aav1483. Epub 2018 Dec 13. Science. 2019. PMID: 30545844
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study.
Hughes DA, Nicholls K, Shankar SP, Sunder-Plassmann G, Koeller D, Nedd K, Vockley G, Hamazaki T, Lachmann R, Ohashi T, Olivotto I, Sakai N, Deegan P, Dimmock D, Eyskens F, Germain DP, Goker-Alpan O, Hachulla E, Jovanovic A, Lourenco CM, Narita I, Thomas M, Wilcox WR, Bichet DG, Schiffmann R, Ludington E, Viereck C, Kirk J, Yu J, Johnson F, Boudes P, Benjamin ER, Lockhart DJ, Barlow C, Skuban N, Castelli JP, Barth J, Feldt-Rasmussen U. Hughes DA, et al. Among authors: Barth J. J Med Genet. 2017 Apr;54(4):288-296. doi: 10.1136/jmedgenet-2016-104178. Epub 2016 Nov 10. J Med Genet. 2017. PMID: 27834756 Free PMC article. Clinical Trial.
Comparative efficacy and acceptability of antidepressants, psychological interventions, and their combination for depressive disorder in children and adolescents: protocol for a network meta-analysis.
Zhou X, Cipriani A, Zhang Y, Cuijpers P, Hetrick SE, Weisz JR, Pu J, Giovane CD, Furukawa TA, Barth J, Coghill D, Leucht S, Yang L, Ravindran AV, Xie P. Zhou X, et al. Among authors: Barth J. BMJ Open. 2017 Aug 11;7(8):e016608. doi: 10.1136/bmjopen-2017-016608. BMJ Open. 2017. PMID: 28801423 Free PMC article.
Combined Anterior Cruciate Ligament Repair and Anterolateral Ligament Reconstruction.
Delaloye JR, Murar J, Vieira TD, Saithna A, Barth J, Ouanezar H, Sonnery-Cottet B. Delaloye JR, et al. Among authors: Barth J. Arthrosc Tech. 2018 Dec 10;8(1):e23-e29. doi: 10.1016/j.eats.2018.08.025. eCollection 2019 Jan. Arthrosc Tech. 2018. PMID: 30899647 Free PMC article.
Wearable sensors objectively measure gait parameters in Parkinson's disease.
Schlachetzki JCM, Barth J, Marxreiter F, Gossler J, Kohl Z, Reinfelder S, Gassner H, Aminian K, Eskofier BM, Winkler J, Klucken J. Schlachetzki JCM, et al. Among authors: Barth J. PLoS One. 2017 Oct 11;12(10):e0183989. doi: 10.1371/journal.pone.0183989. eCollection 2017. PLoS One. 2017. PMID: 29020012 Free PMC article.
Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial.
Rummel M, Kaiser U, Balser C, Stauch M, Brugger W, Welslau M, Niederle N, Losem C, Boeck HP, Weidmann E, von Gruenhagen U, Mueller L, Sandherr M, Hahn L, Vereshchagina J, Kauff F, Blau W, Hinke A, Barth J; Study Group Indolent Lymphomas. Rummel M, et al. Among authors: Barth J. Lancet Oncol. 2016 Jan;17(1):57-66. doi: 10.1016/S1470-2045(15)00447-7. Epub 2015 Dec 5. Lancet Oncol. 2016. PMID: 26655425 Clinical Trial.
1,281 results
Jump to page
Feedback